Multi-mode Stroke Rehabilitation System: Development and Validation of Clinical Efficacy

November 23, 2021 updated by: Chang Gung Memorial Hospital

A Novel, Digital, and Interactive Multi-mode Stroke Rehabilitation System of Arm and Hand: Development and Validation of Clinical Efficacy

The specific study aims will be:

  1. To develop the novel, digital, and interactive MSR system of arm and hand with integrated digital action observation therapy (AOT) and mirror therapy (MT).
  2. To pilot usability testing for examining the feasibility of this new MSR system from the users' experiences and feedback.
  3. To examine the treatment effects of digital AOT, digital MT and a control intervention in patients with stroke by conducting a randomized controlled trial.
  4. To identify who will be the possible good responders to digital AOT and MT based on their baseline motor function and mental imagery abilities.

Study Overview

Detailed Description

Phase I: Multi-mode stroke rehabilitation (MSR) System Development & Usability Testing

Ten patients with stroke and 4 certified occupational therapists were recruited in this phase I study. During the pilot testing, each stroke patient will try to use each training mode of digital AOT and MT by the assistance of the therapist. At the end of the pilot testing, the patients and the therapists will be asked to complete the System Usability Scale and a self-designed questionnaire to assess the user experience and perspective about this new MSR system and their view of its suitability for stroke patients.

Phase II: Validation of Clinical Treatment Efficacy

This three-arm, single-blind, randomized controlled trial will investigate the treatment effects among the 3 groups of digital AOT, digital MT, and dose-matched control intervention. An estimated 60 patients with stroke will be recruited to participate in this phase II study. Each participant will receive a total of 15 training sessions (60 minutes per session) for 3 to 4 weeks. Clinical outcome measures will be conducted at baseline, immediately after treatment (the fourth week), and at 1 month follow-up after treatment.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • New Taipei City, Taiwan, 24213
        • Taipei Hospital, Ministry of Health and Welfare
      • Taoyuan City, Taiwan, 333
        • Taoyuan Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Phase I: Multi-mode stroke rehabilitation (MSR) System Development and Usability Testing

For stroke patients

Inclusion Criteria:

  • diagnosed as having a unilateral stroke;
  • aged from 20 to 80 years;
  • a baseline score of the Fugl-Meyer Assessment in a range of 20 to 60;
  • able to follow the instructions and able to provide user feedback verbally;
  • without aphasia and neglect

For therapists

Inclusion Criteria:

  • holding an occupational therapist license

Phase II: Validation of Clinical Treatment Efficacy

Inclusion Criteria:

  • diagnosed as having a unilateral stroke;
  • at least 6 months after stroke onset;
  • aged from 20 to 80 years;
  • a baseline score of FMA in a range of 20 to 60;
  • able to follow the study instructions;
  • capable of participating in therapy and assessment sessions

Exclusion Criteria:

  • global or receptive aphasia,
  • severe neglect,
  • major medical problems or comorbidities that have influenced upper-limb usage or caused severe pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Digital Action Observation Therapy (Digital AOT)
The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.
The participants will be asked to observe videos and then practice what the participants observed.
Experimental: Digital Mirror Therapy (Digital MT)
The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.
The participants will observe the real-time self-recorded visual illusion, and move their upper limbs as could as possible.
Active Comparator: Conventional Occupational Therapy
The common categories of motor actions and tasks will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movement or object manipulation, and (c) upper-limb functional tasks.
The participants will receive upper-limb training without providing videos for observing neither providing them mirror illusions of movements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change scores of Fugl-Meyer Assessment
Time Frame: baseline, 4 weeks, 2 months
The upper-limb subsection of Fugl-Meyer Assessment is a measure with sound psychometric properties to evaluate motor impairments.
baseline, 4 weeks, 2 months
Change scores of Movement Imagery Questionnaire-Revised, Second Edition
Time Frame: baseline, 4 weeks, 2 months
The Movement Imagery Questionnaire-Revised, Second Edition is a 14-item questionnaire with sound reliability and validity to evaluate the ability of motion imagination in patients with stroke.
baseline, 4 weeks, 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change scores of Chedoke Arm and Hand Activity Inventory
Time Frame: baseline, 4 weeks, 2 months
The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to assess the independence of stroke patients to perform activities of daily living with an affected upper limb.
baseline, 4 weeks, 2 months
Change scores of Box and Block Test
Time Frame: baseline, 4 weeks, 2 months
The Box and Block Test is a tool with sound reliability and validity to evaluate hand dexterity of stroke patients.
baseline, 4 weeks, 2 months
Change scores of Revised Nottingham Sensory Assessment
Time Frame: baseline, 4 weeks, 2 months
The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to assess sensory function in patients with stroke.
baseline, 4 weeks, 2 months
Change scores of Barthel Index
Time Frame: baseline, 4 weeks, 2 months
The Barthel Index is a validated tool designed to measure activities reflecting the daily living independence.
baseline, 4 weeks, 2 months
Change scores of Motor Activity Log
Time Frame: baseline, 4 weeks, 2 months
The Motor Activity Log is a semi-structured interview with good psychometric properties to assess the level of use of affected upper limb in 30 main activities of daily living.
baseline, 4 weeks, 2 months
Change scores of the health state of EQ-5D-5L
Time Frame: baseline, 4 weeks, 2 months
The questionnaire of EQ-5D-5L contains 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5 dimensions represents the health state.
baseline, 4 weeks, 2 months
Change scores of the visual analogue scale (VAS) of EQ-5D-5L
Time Frame: baseline, 4 weeks, 2 months
The VAS of EQ-5D-5L scores will be scored from 0 to 100, with a higher score indicating better overall current health.
baseline, 4 weeks, 2 months
Change of joint angles of OPAL wearable sensors
Time Frame: baseline, 4 weeks, 2 months
The OPAL wearable sensors is used to objectively record the movements of an affected upper limb in patients with stroke in real time, such as joint angles. Joint angles of the shoulder, elbow, and wrist will be calculated.
baseline, 4 weeks, 2 months
Change of joint velocity of OPAL wearable sensors
Time Frame: baseline, 4 weeks, 2 months
The OPAL wearable sensors is used to objectively record the movements of an affected upper limb in patients with stroke in real time, such as joint velocity. The angular velocity of shoulder, elbow, and wrist will be also collected.
baseline, 4 weeks, 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu-Wei Hsieh, PhD, Department of Occupational Therapy, College of Medicine, Chang Gung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 3, 2020

Primary Completion (Actual)

May 11, 2021

Study Completion (Actual)

July 31, 2021

Study Registration Dates

First Submitted

June 16, 2020

First Submitted That Met QC Criteria

June 18, 2020

First Posted (Actual)

June 22, 2020

Study Record Updates

Last Update Posted (Actual)

November 26, 2021

Last Update Submitted That Met QC Criteria

November 23, 2021

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Digital Action Observation Therapy (Digital AOT)

3
Subscribe